Report ID: SQMIG35D2206
Report ID:
SQMIG35D2206 |
Region:
Global |
Published Date: July, 2024
Pages:
219
|
Tables:
91 |
Figures:
66
In 2023, North America emerged as the revenue leader, asserting dominance within the market landscape. This stronghold can be attributed to several factors, notably the region's well-established healthcare infrastructure, coupled with a heightened awareness of chronic kidney disease (CKD) among both healthcare professionals and the general populace. Additionally, the region benefits from favorable reimbursement policies and proactive governmental initiatives aimed at bolstering healthcare accessibility and affordability.
Anticipated to showcase a substantial CAGR of 8.34% over the forecast period, the Asia Pacific region is poised for significant expansion within the Kidney function tests market. This growth trajectory is notably propelled by the escalating prevalence of kidney diseases in the region, signaling a pressing healthcare concern. For instance, data from the Australian Institute of Health and Welfare in 2020 revealed a stark reality, with approximately 17,700 individuals succumbing to chronic kidney disease (CKD) in Australia alone.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35D2206